National Vision Holdings, Inc. (EYE)
Ophthalmic Goods · Healthcare · $1.4B
Intrinsic Value (Consensus)
$8.73
Current Price
$17.57
Margin of Safety
-50.3%
50.3% Above Intrinsic Value
Value: $9
Price: $18
Valuation Model Estimates
Current Price: $17.57
DCF (Discounted Cash Flow)
$14.43
Graham Number
$9.51
Earnings Power Value
$3.59
Relative Value (P/E)
$7.40
Dividend Discount Model
Not applicable
—
Consensus Value
$8.73
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
53
Profitability
12/25
Strength
24/25
Valuation
7/25
Growth
10/25
Financial Health Signals
Low debt — conservative balance sheet
Key Financials
- EPS (TTM)
- $0.37
- EPS (Forward)
- $0.39
- Book Value
- $10.85
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- 3.4%
- Debt/Equity
- 27%
- Revenue Growth
- 9.0%
- Earnings Growth
- 5.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance